Compare Dow Inc (DOW) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dow Inc vs Novartis AG — how do they compare? Dow Inc trades at $31.24 (market cap $22.58B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 13.1× Dow Inc's market cap, and Dow Inc pays the higher dividend (4.48%). Which is the better fit depends on your goals.
| DOW | NVS | |
|---|---|---|
Market Cap | $22.58B | $295.37B |
Sector | Basic Materials | Health |
52-Week High | $41.87 | $168.62 |
52-Week Low | $20.65 | $119.31 |
Enterprise Value | $38.27B | $336.69B |
Dividend Yield | 4.48% | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dow Inc
Dow Inc is a diversified chemical manufacturing company. It combining science and technology to develop innovative solutions that are essential to human progress. Dow's portfolio is comprised of six global business units, organized into three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings.
Read more on DOW →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
